Hydrochloric Acid → (2R)-3-[3-bromo-4-(1,1-dioxido-3-oxoisothiazolidin-5-yl)phenyl]-2-[(phenylsulfonyl)-amino]propanoic Acid
반응식
FC(F)(F)C(O)=O.[NH2:8][C@@H:9]([CH2:14][C:15]1[CH:20]=[CH:19][C:18]([CH:21]2[S:25](=[O:27])(=[O:26])[NH:24][C:23](=[O:28])[CH2:22]2)=[C:17]([Br:29])[CH:16]=1)[C:10]([O:12]C)=[O:11].C(N(CC)CC)C.[C:37]1([S:43](Cl)(=[O:45])=[O:44])[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=1.[OH-].[Li+].Cl>CO.O>[Br:29][C:17]1[CH:16]=[C:15]([CH2:14][C@@H:9]([NH:8][S:43]([C:37]2[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=2)(=[O:45])=[O:44])[C:10]([OH:12])=[O:11])[CH:20]=[CH:19][C:18]=1[CH:21]1[S:25](=[O:27])(=[O:26])[NH:24][C:23](=[O:28])[CH2:22]1참가 물질
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
Methyl (2S)-2-amino-3-[3-bromo-4-(1,1-dioxido-3-oxoisothiazolidin-5-yl)-phenyl]-propanoate trifluoroacetate (77.1 mg, 0.152 mmol) in methanol (1.7 mL,) was treated with triethylamine (85.0 μL, 0.610 mmol) and then benzenesulfonyl chloride (29.2 μL, 0.228 mmol). The solution was stirred at rt for 2 h. 4 M lithium hydroxide in water (0.38 mL) was added and stirred for 3 h at rt. The solution was acidified with aqueous 1 N hydrochloric acid solution (4 mL), diluted with methanol (1.5 mL) and purified by preparative LCMS to afford product as a white solid (55.4 mg, 70%). 1H NMR (400 MHz, CD3OD): δ 7.65–7.62 (m, 2H), 7.53–7.36 (m, 4H), 7.25–7.20 (m, 1H), 5.65 (t, J=6.8 Hz, 1H), 4.06–5.01 (m, 1H), 3.48 (dd, J=16.2, 8.0 Hz, 1H), 3.38–3.28 (m, 1H), 3.11–3.06 (m, 1H), 2.87–2.83 (m, 1H); LCMS found for C18H18BrN2O7S2 (M+H)+: m/z=517.
후처리
- stirringstirred for 3 h at rt
- custompurified by preparative LCMS
출처 및 근거
- ORD 기록
- ord-fd98c279e8074310afce4367d104a61a
- 출처 데이터셋
- uspto-grants-2006_11
- 특허 번호
- US07141596B2
반응 노트
불러오는 중…